https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363
Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.
zc:3358161203278348112
0
https://www.zacks.com/stock/news/2215362/dominion-energy-d-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2215362
Jan 24, 2024 - The latest trading day saw Dominion Energy (D) settling at $44.15, representing a -1.45% change from its previous close.
zc:-4710600096356244242
0
https://www.zacks.com/stock/news/2216056/nextera-energy-nee-q4-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2216056
Jan 25, 2024 - NextEra Energy (NEE) posts better-than-expected fourth-quarter earnings and revenues. It continues to gain from the thriving Florida economy.
zc:-3510699775151165611
0
https://www.zacks.com/stock/news/2218877/2seventy-bio-tsvt-divests-r-d-assets-to-regeneron-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218877
Jan 31, 2024 - 2seventy bio (TSVT) inks an asset purchase agreement with Regeneron to sell its oncology and autoimmune pipeline to the latter.
zc:6104452854925000797
0
https://www.zacks.com/stock/news/2222832/exelixis-exel-q4-earnings-beat-on-lower-r-d-spend-sales-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-2222832
Feb 07, 2024 - Exelixis (EXEL) surpasses earnings estimates in the fourth quarter on lower R&D expenses. Sales, however, miss estimates.
zc:-2857636453158293286
0
https://www.zacks.com/stock/news/2223998/can-southern-so-q4-earnings-maintain-its-beat-streak?cid=CS-ZC-FT-analyst_blog|earnings_preview-2223998
Feb 09, 2024 - Customer additions and lower costs are likely to have boosted The Southern Company's (SO) profit levels in the fourth quarter.
zc:5744089117400289393
0
https://www.zacks.com/stock/news/2227416/one-gas-ogs-to-post-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2227416
Feb 16, 2024 - ONE Gas' (OGS) Q4 earnings are likely to have gained from customer growth and the implementation of new rates, while increasing expenses might have offset the upsides.
zc:-553346386902460795
0
https://www.zacks.com/stock/news/2228102/dominion-energy-d-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228102
Feb 19, 2024 - Dominion Energy's (D) fourth-quarter results are likely to benefit from higher sales volume, while the high interest rate and planned outage of Millstone Power Station will offset some positives.
zc:3180322021929171528
0
https://www.zacks.com/stock/news/2237695/insiders-are-buying-these-5-stocks?cid=CS-ZC-FT-stocks_in_the_news-2237695
Mar 07, 2024 - Many investors closely monitor insider buys, as they can provide insight into the longer-term picture. And recently, insiders of these five companies have made splashes.
zc:3937119680675919590
0
https://www.zacks.com/stock/news/2239615/dominion-energy-d-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2239615
Mar 12, 2024 - The latest trading day saw Dominion Energy (D) settling at $46.98, representing a -1.39% change from its previous close.
zc:-2379334104934112467
0